Pro Medicus Limited Stock
Stocks
PME
AU000000PME8
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
01:14:08 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 196.20 AUD | -0.45% |
|
-1.10% | -11.17% |
| 10-19 | Jefferies Adjusts Price Target on Pro Medicus to AU$198.30 | MT |
| 10-18 | Jefferies Adjusts Price Target on Pro Medicus to AU$198.30 | MT |
| Market Cap | 20.5B 14.42B 12.91B 11.88B 10.76B 20.12B 1,369B 142B 56.87B 720B 54.12B 52.97B 2,271B | P/E 2027 * |
109x | P/E 2028 * | 85.7x |
|---|---|---|---|---|---|
| Enterprise Value | 20.2B 14.21B 12.73B 11.71B 10.61B 19.83B 1,350B 140B 56.06B 710B 53.34B 52.21B 2,239B | EV / Sales 2027 * |
59.7x | EV / Sales 2028 * | 47.8x |
| Free-Float |
51.04% | Yield 2027 * |
0.48% | Yield 2028 * | 0.58% |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PME | Delayed | |
OTC Markets
| PMCUF | Delayed | |
|
Tradegate
| PMC | Real-time | |
|
Boerse Muenchen
| PMC | Real-time | |
|
Deutsche Boerse AG
| PMC | Delayed |
Last Transcript: Pro Medicus Limited
| 1 day | -0.45% | ||
| 1 week | -1.10% | ||
| 1 month | +19.69% | ||
| 3 months | +20.95% | ||
| 6 months | +45.98% | ||
| Current year | -11.17% |
| 1 week | 194 |  | 203 |
| 1 month | 154.15 | | 203 |
| Current year | 107.75 | | 223.02 |
| 1 year | 107.75 | | 272.85 |
| 3 years | 78.83 | | 336 |
| 5 years | 36.54 | | 336 |
| 10 years | 4.27 | | 336 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Hupert
CEO | Chief Executive Officer | - | 2010-09-30 |
Anthony Hall
CTO | Chief Tech/Sci/R&D Officer | - | - |
Danny English
DFI | Director of Finance/CFO | - | 2026-03-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Hall
BRD | Director/Board Member | - | 1982-12-31 |
Peter Kempen
CHM | Chairman | 75 | 2010-07-31 |
Anthony Glenning
BRD | Director/Board Member | - | 2016-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/25/26 | Buy | Founder | 8,146 | 0.0078% | ||
| 2/25/26 | Buy | Founder | 9,000 | 0.0086% | ||
| 2/24/26 | Buy | Founder | 8,500 | 0.0081% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.45% | -1.10% | -25.57% | +163.21% | 14.42B | |
| -1.72% | +3.44% | +22.84% | +56.71% | 258B | |
| -2.00% | +0.75% | +7.82% | +20.94% | 163B | |
| -3.73% | -4.48% | -19.14% | +64.75% | 150B | |
| -1.66% | -8.12% | -58.32% | -17.99% | 60.84B | |
| -.--% | +2.46% | -11.69% | -7.41% | 53.31B | |
| -2.57% | +3.30% | +11.59% | +44.40% | 53.03B | |
| +0.84% | -3.12% | +7.47% | +62.40% | 50.67B | |
| -3.47% | +1.04% | +19.48% | +69.17% | 49.3B | |
| -3.61% | +1.99% | +32.36% | +93.99% | 45.46B | |
| Average | -1.84% | -0.38% | -1.32% | +55.02% | 89.84B | |
| Weighted average by Cap. | -2.08% | +0.13% | +3.56% | +46.56% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 339M 238M 213M 196M 178M 332M 22.62B 2.34B 940M 11.9B 894M 875M 37.53B | 420M 296M 265M 244M 221M 412M 28.07B 2.9B 1.17B 14.77B 1.11B 1.09B 46.57B |
| Net income | 186M 131M 117M 108M 97.5M 182M 12.4B 1.28B 515M 6.52B 490M 480M 20.57B | 239M 168M 151M 139M 126M 235M 15.97B 1.65B 663M 8.4B 631M 618M 26.49B |
| Net Debt | -293M -206M -185M -170M -154M -288M -19.59B -2.03B -814M -10.3B -774M -758M -32.5B | -405M -285M -255M -235M -213M -398M -27.06B -2.8B -1.12B -14.24B -1.07B -1.05B -44.89B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | A$196.20 | -0.45% | 231,516 |
| 26-10-29 | A$197.09 | +0.56% | 153,922 |
| 26-10-28 | A$196.00 | -1.21% | 186,618 |
| 26-10-27 | A$198.41 | -1.40% | 367,874 |
| 26-10-26 | A$201.22 | +1.43% | 283,188 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PME Stock
Select your edition
All financial news and data tailored to specific country editions
